Crossmark

Vemurafenib en el tratamiento de glioblastoma con mutación BRAF V600: a propósito de un caso

Crossref DOI link: https://doi.org/10.1016/j.farma.2025.03.013

Published Print: 2025-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

de la Fuente Villaverde, Irene

Caso González, Alicia

Carbajales Álvarez, Mónica

Martínez Torrón, Alba

Fernández Lastras, Sergio

García Llano, Juan Luis

Lozano Blázquez, Ana
License Information

Text and Data Mining valid from 2025-09-01

Text and Data Mining valid from 2025-09-01

Version of Record valid from 2025-03-25
More Information

This article is maintained by: Elsevier

Article Title: Vemurafenib en el tratamiento de glioblastoma con mutación BRAF V600: a propósito de un caso

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2025.03.013

Content Type: article

Copyright: © 2025 The Author(s). Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Farmacia Hospitalaria (S.E.F.H).